Dun & Bradstreet (DNB) Tops Q1 EPS by 5c, Reaffirms Guidance
Get Alerts DNB Hot Sheet
Price: $9.15 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding - Basic: 36.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Weighted Average Number of Shares Outstanding - Basic: 36.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Dun & Bradstreet (NYSE: DNB) reported Q1 EPS of $0.95, $0.05 better than the analyst estimate of $0.90. Revenue for the quarter came in at $383.8 million versus the consensus estimate of $380.04 million.
Full Year 2017 Guidance
Dun & Bradstreet today reaffirmed its financial guidance for the full year 2017:
- Organic revenue growth of 1% to 3%, before the effect of foreign exchange;
- As Adjusted total revenue growth of 3% to 5%, before the effect of foreign exchange;
- As Adjusted operating income about flat, in the range of (2%) to 2% versus prior year;
- As Adjusted diluted EPS of (4%) to (9%) versus prior year; and
- Free cash flow of $215 million to $245 million, which excludes any potential regulatory fines associated with our China operations.
For earnings history and earnings-related data on Dun & Bradstreet (DNB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share